Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success

Filetype[PDF-1.01 MB]


  • English
    • Details Supporting Files You May Also Like

    Details:

    • Alternative Title:
      PLoS Negl Trop Dis
    • Personal Author:
    • Description:
      Lymphatic filariasis (LF) is caused by filarial worms that live in the lymphatic system and commonly lead to lymphoe- dema, elephantiasis, and hydrocele. LF is recognized as endemic in 73 countries and territories; an estimated 1.39 billion (thou- sand million) people live in areas where filariasis has been endemic and is now targeted for treatment [1]. Global mo- mentum to eliminate LF has developed over the past 15 years as a result not only of research demonstrating the value of single-dose treatment strategies and point- of-care diagnostic tools, but also of both the generous donations of medicines from the following committed pharmaceutical companies: GlaxoSmithKline (albenda- zole), Merck (ivermectin), and Eisai (di- ethylcarbamazine; DEC), and the essential financial support for programme imple- mentation from the donor community [2]. During 2011, more than 50 countries carried out LF elimination programmes, and more than 500 million people re- ceived mass treatment [1]. A principal reason for the programme’s dramatic expansion and success to date has been the galvanizing of efforts of all key partners around a common policy framework created and coordinated through the World Health Organization’s Global Pro gramme to Eliminate Lymphatic Filariasis (GPELF). This report, rather than high- lighting the very considerable contribu- tions of each individual partner or even chronicling most of the specific achieve- ments of the GPELF, instead focuses on the details of the underlying processes themselves and their importance in deter- mining programme success.
    • Subjects:
    • Source:
      PLoS Negl Trop Dis. 2014; 8(12).
    • Document Type:
      Journal Article
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov